Dorsey Wright & Associates’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,086
Closed -$9K 290
2019
Q1
$9K Sell
1,086
-1,083
-50% -$8.98K ﹤0.01% 193
2018
Q4
$18K Buy
+2,169
New +$18K 0.01% 146